Suppr超能文献

结直肠病理 T1 期肿瘤患者术后复发的危险因素。

Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer.

机构信息

Department of Surgery, School of Medicine, Keio University, 35 Shinanomachi Shinjuku-ku, Tokyo, Japan.

出版信息

World J Surg. 2012 Feb;36(2):424-30. doi: 10.1007/s00268-011-1378-y.

Abstract

BACKGROUND

The evolution of diagnostic procedures has resulted in an increase in early detection of pathologically T1 (pT1) colorectal cancer (CRC). However, the risk factors affecting long-term outcomes of patients with pT1 CRCs have been unclear. The aim of the present study was to identify risk factors for postoperative recurrence and overall survival in patients with pT1 CRC.

METHODS

Between January 1990 and January 2003, a total of 284 patients with pT1 CRC underwent radical surgery in the authors' institution. The impact of clinicopathological factors on postoperative recurrence and overall survival was estimated by univariate and multivariate analysis.

RESULTS

The median follow-up period was 55 months (interquartile range: 47.1 months). Postoperative recurrence occurred in 8 (2.8%) patients. The overall 5-year and 10-year disease-free survival rates were 98.4 and 92.7%. Multivariate analysis showed the presence of lymphatic invasion only was an independent risk factor for postoperative recurrence in pT1 CRC patients (hazard ratio: 11.622; P = 0.003). The 5-year and 10-year disease-free survival rates of the patients in N-ly- group, the N-ly + group, and the N+ group were 99.5%/98.2% and 96.3%/75.2%, and 93.3%/93.3%, respectively. Additionally, 4 of the 8 recurrences were found more than 5 years after the operation.

CONCLUSIONS

Lymphatic invasion was an independent risk factor for recurrence in pT1 CRC patients.

摘要

背景

诊断程序的发展导致病理性 T1(pT1)结直肠癌(CRC)的早期检测有所增加。然而,影响 pT1 CRC 患者长期预后的危险因素尚不清楚。本研究旨在确定影响 pT1 CRC 患者术后复发和总生存率的危险因素。

方法

1990 年 1 月至 2003 年 1 月,作者所在机构共对 284 例 pT1 CRC 患者行根治性手术。通过单因素和多因素分析评估临床病理因素对术后复发和总生存的影响。

结果

中位随访时间为 55 个月(四分位距:47.1 个月)。8 例(2.8%)患者术后复发。总的 5 年和 10 年无病生存率分别为 98.4%和 92.7%。多因素分析显示,仅存在淋巴管浸润是 pT1 CRC 患者术后复发的独立危险因素(风险比:11.622;P = 0.003)。N-ly-组、N-ly+组和 N+组的患者 5 年和 10 年无病生存率分别为 99.5%/98.2%和 96.3%/75.2%,93.3%/93.3%。此外,8 例复发中有 4 例发生在术后 5 年以上。

结论

淋巴管浸润是 pT1 CRC 患者复发的独立危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验